Carcinogenesis, Vol. 24, No. 3, 385-392,
March 2003
© 2003 Oxford University Press
CANCER BIOLOGY |
The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE2 synthesis and cytotoxicity in human colorectal carcinoma cell lines
1 WUR/TNO Centre for Food Toxicology,
2 Division of Toxicology, Wageningen University, Tuinlaan, PO Box 8000, 6700 EA Wageningen,
3 TNO Nutrition and Food Research, Department of Biomolecular Sciences, Utrechtseweg 48, PO Box 360, 3700 AJ Zeist, The Netherlands
This study was conducted to investigate the role of the enzyme cyclooxygenase (COX) and its prostaglandin product PGE2 in n-6 and n-3 polyunsaturated fatty acid (PUFA)-mediated effects on cellular proliferation of two human colorectal carcinoma cell lines. The long chain PUFAs eicosapentaenoic acid (EPA; 20:5n-3) and arachidonic acid (AA; 20:4n-6) both inhibited cell proliferation of Caco-2 cells compared with the long chain fatty acids
-linolenic acid (ALA; 18:3n-3) and linoleic acid (LA; 18:2n-6). Neither incubation with PGE2 nor reduction in PGE2 synthesis by EPA compared with AA led to differential effects on cell proliferation in Caco-2 cells. This suggests that n-6 and n-3 PUFA-mediated cell proliferation in Caco-2 cells is not regulated via PGE2 levels. AA and EPA had no effect on growth of HT-29 colon cancer cells with a low COX activity. However, stimulation of COX-2 activity by IL-1ß resulted in a decrease in cell proliferation and an induction of cytotoxicity by AA as well as by EPA. Both inhibition of the COX pathway by indomethacin as well as inhibition of direct lipid peroxidation by antioxidants such as vitamin E and C diminished the anti-proliferative effects of AA as well as EPA. Also, malondialdehyde, a product of lipid peroxidation and COX-activity was decreased by addition of vitamin E and partially decreased by indomethacin. These data support the hypothesis that growth inhibitory and cytotoxic effects of PUFAs with methylene-interrupted double bonds such as AA and EPA are due to peroxidation products that are generated during lipid peroxidation and COX activity.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Hering, S. Garrean, T. R. Dekoj, A. Razzak, A. Saied, J. Trevino, T. A. Babcock, and N. J. Espat Inhibition of Proliferation by Omega-3 Fatty Acids in Chemoresistant Pancreatic Cancer Cells Ann. Surg. Oncol., December 1, 2007; 14(12): 3620 - 3628. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Kim, M. Della-Fera, J. Lin, and C. A. Baile Docosahexaenoic Acid Inhibits Adipocyte Differentiation and Induces Apoptosis in 3T3-L1 Preadipocytes J. Nutr., December 1, 2006; 136(12): 2965 - 2969. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Schroder, Y. Yudina, A. Sabirsh, N. Zahn, J. Z. Haeggstrom, and J. Stein 15-deoxy-{Delta}12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells J. Lipid Res., May 1, 2006; 47(5): 1071 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Calviello, F. Di Nicuolo, S. Gragnoli, E. Piccioni, S. Serini, N. Maggiano, G. Tringali, P. Navarra, F. O. Ranelletti, and P. Palozza n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1{alpha} induction pathway Carcinogenesis, December 1, 2004; 25(12): 2303 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hinz, R. Ramer, K. Eichele, U. Weinzierl, and K. Brune Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells Mol. Pharmacol., December 1, 2004; 66(6): 1643 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin, S. M. Zhang, N. R. Cook, I-M. Lee, and J. E. Buring Dietary Fat and Fatty Acids and Risk of Colorectal Cancer in Women Am. J. Epidemiol., November 15, 2004; 160(10): 1011 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C Larsson, M. Kumlin, M. Ingelman-Sundberg, and A. Wolk Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms Am. J. Clinical Nutrition, June 1, 2004; 79(6): 935 - 945. [Abstract] [Full Text] [PDF] |
||||






